Israel Englander Avadel Pharmaceuticals PLC Call Options Transaction History

Millennium Management LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2023 May 15, 2023	BUY	$6.41 - $9.95 $82,048 - $127,359	12,800 Added 5.4%	250,000 $2.29 Million
Q4 2022 Feb 14, 2023	BUY	$5.02 - $10.0 $1.19 Million - $2.37 Million	237,200 New	237,200 $1.7 Million

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.